Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

Overview of attention for article published in Breast Cancer Research, June 2005

Altmetric Badge

Mentioned by

patent: 13 patents

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 56 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 13 patents that reference this research output.

PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds

Grant US-11918649-B2

United States of America

Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targe…

Grant US-11857628-B2

United States of America

CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors

Grant US-11713347-B2

United States of America

Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

Grant US-11591579-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 9 additional patents.